The University of Stellenbosch
Home » Publications

Publications during 2021

In 2021, team members from the DTTC contributed to publications on various academic platforms.

Desmond Tutu TB Centre: Publications 2021

  1. Allwood, B.W., Byrne, A., Meghji, J., Rachow, A., van der Zalm, M.M. and Schoch, O.D. Post-tuberculosis lung disease: Clinical review of an under-recognised global challenge. Respiration. 2021 Jan 5;100(1):11-23. PMID: 33401266.
  2. Allwood, B.W., Stolbrink, M., Baines, N., Louw, E., Wademan, D.T., Lupton-Smith, A., Nel, S., Maree, D., Mpagama, S., Osman, M., Marx, F.M., Hoddinott, G., Lesosky, M., Rylance, J., and Mortimer, K. On behalf of the lung health in Africa across. Persistent chronic respiratory symptoms despite TB cure is poorly correlated with lung function. The International Journal of Tuberculosis and Lung Disease. 2021 Apr 1;25(4):262-70. PMID: 33762069.
  3. Allwood, B.W., van der Zalm, M.M. and Mortimer, K. Reply to: Taking action to improve post‐TB lung health. The International Journal of Tuberculosis and Lung Disease. 2021 Feb 1;25(2):163a-163. PMID: 33656434.
  4. Baliashvili, D., Gandhi, N.R., Kim, S., Hughes, M., Mave, V., Mendoza-Ticona, A., Gonzales, P., Kim, N., Selvamuthu, P., Badal-Faesen, S., Upton, C., Naini, L., Smith, E., Gupta, A., Churchyard, G., Swindells, S., Hesseling, A., and Shah, N.S.. Resistance to Mycobacterium tuberculosis infection among household contacts: A multinational study. Clin Infect Dis. 2021 Mar 27:ciab269. Epub ahead of print. PMID: 33772550
  5. Basu Roy, R., Bakeera-Kitaka, S., Chabala, C., Gibb, D.M., Huynh, J., Mujuru, H., Sankhyan, N., Seddon, J.A., Sharma, S., Singh, V., and Wobudeya, E. Defeating paediatric tuberculous meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap”. Microorganisms. 2021 Apr;9(4):857. PMID: 33923546.
  6. Bekker, A., Rabie, H., Salvadori, N., du Toit, S., Than-In-At, K., Groenewald, M., Andrieux-Meyer, I., Kumar, M., Cressey, R., Nielsen, J., Capparelli, E. Pharmacokinetics and safety of the abacavir/lamivudine/lopinavir/ritonavir fixed-dose granule formulation (4-in-1) in neonates: PETITE study. Journal of Acquired Immune Deficiency Syndromes (1999). 2021 Dec 2. PMID: 34855626.
  7. Bell-Mandla, N.F., Sloot, R., Maarman, G., Griffith, S., Moore, A., Floyd, S., Hayes, R., Fidler, S., Ayles, H., and Bock, P. Improving retention of community-recruited participants in HIV prevention research through Saturday household visits; findings from the HPTN 071 (PopART) study in South Africa. BMC Medical Research Methodology. 2021 Dec;21(1):1-8. PMID: 34749654 PMCID: PMC8574030.
  8. Bond, V., Hoddinott, G., Viljoen, L., Ngwenya, F., Simuyaba, M., Chiti, B., Ndubani, R., Makola, N., Donnell, D., Schaap, A., and Floyd, S. How ‘place’ matters for addressing the HIV epidemic: Evidence from the HPTN 071 (PopART) cluster-randomised controlled trial in Zambia and South Africa. Trials. 2021 Dec;22(1):1-3. PMID: 33823907.
  9. Chabala, C., Turkova, A., Hesseling, A.C., Zimba, K.M., van der Zalm, M., Kapasa, M., Palmer, M., Chirehwa, M., Wiesner, L., Wobudeya, E., and Kinikar, A. Pharmacokinetics of first-line drugs in children with tuberculosis using WHO-recommended weight band doses and formulations. Clinical Infectious Diseases. 2021 Aug 22. PMID: 34420049.
  10. Demers, A.M., Kim, S., McCallum, S., Eisenach, K., Hughes, M., Naini, L., Mendoza-Ticona, A., Pradhan, N., Narunsky, K., Poongulali, S., Badal-Faesen, S., Upton, C., Smith, E., Shah, N.S., Churchyard, G., Gupta, A., Hesseling, A., and Swindells, S. ACTG A5300/IMPAACT I2003 PHOENIx Feasibility study team. Drug susceptibility patterns of Mycobacterium tuberculosis from adults with multidrug-resistant tuberculosis and implications for a household contact preventive therapy trial. BMC Infect Dis. 2021 Feb 24;21(1):205. PMID: 33627075.
  11. Denti, P., Wasmann, R.E., van Rie, A., Winckler, J., Bekker, A., Rabie, H., Hesseling, A.C., van der Laan, L.E., Gonzalez-Martinez, C., Zar, H.J., Davies, G., Wiesner, L., Svensson, E.M., and McIlleron, H.M. Optimizing dosing and fixed-dose combinations of rifampicin, isoniazid, and pyrazinamide in pediatric patients with tuberculosis: A prospective population pharmacokinetic study. Clin Infect Dis. 2021 Oct 19:ciab908. Online ahead of print. PMID: 34665866.
  12. DODD PJ, YUEN CM, JAYASOORIYA SM, VAN DER ZALM MM, SEDDON JA. Quantifying the global number of tuberculosis survivors: a modelling study. LANCET Infectious Diseases2021; 21:984-992.
  13. DONALD PR, DIACON AH, THEE S. Anton Ghon and His Colleagues and Their Studies of the Primary Focus and Complex of Tuberculosis Infection and Their Relevance for the Twenty-First Century. Respiration2021; 100:557-567.
  14. Dodd, P.J., Osman, M., Cresswell, F.V., Stadelman, A.M., Lan, N.H., Thuong, N.T., Muzyamba, M., Glaser, L., Dlamini, S.S., and Seddon, J.A. The global burden of tuberculous meningitis in adults: A modelling study. PLOS Global Public Health. 2021 Dec 8;1(12):e0000069.
  15. Donald, P.R., Ronge, L., Demers, A.M., Thee, S., Schaaf, H.S., and Hesseling, A.C. Positive mycobacterium tuberculosis gastric lavage cultures from asymptomatic children with normal chest radiography. J Pediatric Infect Dis Soc. 2021 Apr 30;10(4):502-508. PMID: 33079203.
  16. Driessche, K.V., Mahlobo, P.Z., Venter, R., Caldwell, J., Jennings, K., Diacon, A.H., Cotton, M.F., de Groot, R., Hens, N., Marx, F.M., and Warren, R.M. Face masks in the post-COVID-19 era: A silver lining for the damaged tuberculosis public health response? The Lancet Respiratory Medicine. 2021 Apr 1;9(4):340-2. PMID: 33493446.
  17. du Preez, K., Osman, M., Seddon, J.A., Naidoo, P., Schaaf, H.S., Munch, Z., Dunbar, R., Mvusi, L., Dlamini, S.S., and Hesseling, A.C. The impact of the evolving HIV response on the epidemiology of tuberculosis in South African children and adolescents. Clinical Infectious Diseases. 2021 Aug 15;73(4):e967-75. PMID: 33532853.
  18. Garcia-Prats, A.J., Salazar-Austin, N., Conway, J.H., Radtke, K., LaCourse, S.M., Maleche-Obimbo, E., Hesseling, A.C., Savic, R.M., and Nachman, S. Coronavirus disease 2019 (COVID-19) pharmacologic treatments for children: Research priorities and approach to pediatric studies. Clin Infect Dis. 2021 Mar 15;72(6):1067-1073. PMID: 32594142.
  19. Garcia-Prats, A.J., Svensson, E.M., Winckler, J., Draper, H.R., Fairlie, L., van der Laan, L.E., Masenya, M., Schaaf, H.S., Wiesner, L., Norman, J., and Aarnoutse, R.E. Pharmacokinetics and safety of high-dose rifampicin in children with TB: The Opti-Rif trial. Journal of Antimicrobial Chemotherapy. 2021 Dec;76(12):3237-46. PMID: 34529779.
  20. Gausi, K., … , Hesseling, A., … Theron, G., Weinberg, A., Gupta, A., and Denti, P. IMPAACT P1078 (TB APPRISE) Study Group Team. Pharmacokinetics and drug-drug interactions of Isoniazid and Efavirenz in pregnant women living with HIV in high TB incidence settings: Importance of genotyping. Clin Pharmacol Ther. 2021. Apr;109(4):1034-1044. Epub 2020 Oct 16. PMID: 32909316.
  21. Ghanaie, R.M., Karimi, A., Azimi, L., Seddon, J., Nasehi, M., Mishkar, A.P., Sheikhi, M., Fallah, F., Tabatabaei, S.R., and Hoseini-Alfatemi, S.M. Diagnosis of latent tuberculosis infection among pediatric household contacts of Iranian tuberculosis cases using tuberculin skin test, IFN-γ release assay and IFN-γ-induced protein-10. BMC Pediatrics. 2021 Dec;21(1):1-8. PMID: 33573613.
  22. Goussard, P., Croucamp, R., Bosch, C., Demers, A.M., Morrison, J., Mfingwana, L., Palmer, M., van der Zalm, M.M., Friedrich, S.O., Janson, J.T., Whitelaw, A.C., Andronikou, S., Hesseling, A.C., Walters, E., and Lopez-Varela, E. Diagnostic utility of bronchoalveolar lavage in children with complicated intrathoracic tuberculosis. Pediatr Pulmonol. 2021 Jul;56(7):2186-2194. Epub 2021 Apr 13. PMID: 33818927.
  23. Gray, D.M., Owusu, S.K., and van der Zalm, M.M. Chronic lung disease in children: Disease focused use of lung function. Current Opinion in Physiology. 2021 May 13.
  24. Greybe, L., Morrison, J.L., Schaaf, H.S., Rabie, H., and Cotton, M.F. The outcome of accidental Bacille Calmette-Guérin (BCG) overdose during routine neonatal immunization. Pediatr Infect Dis J. 2021;40(6):588-589 (Published ahead of print). PMID: 33470774
  25. Gunasekera, K.S., Walters, E., van der Zalm, M.M., Palmer, M., Warren, J.L., Hesseling, A.C., Cohen, T., and Seddon, J.A. Development of a treatment-decision algorithm for HIV-uninfected children evaluated for pulmonary tuberculosis. Clinical Infectious Diseases. 2021 Jan 15. PMID: 33449999.
  26. HESSELING PB, AFUNGCHWI GM, NJAMSHI V, KRUGER M, KIMBI C, WHARIN P, DRAPER HR, KOUYA F. Burkitt lymphoma: Age specific fertility rate in 113 long-term female survivors after treatment with cyclophosphamide. JOURNAL OF TROPICAL PEDIATRICS2021; 67(1):fmab004.

 

  1. Hirsch-Moverman, Y., Howard, A.A., Mantell, J.E., Lebelo, L., Frederix, K., Wills, A., Hesseling, A.C., Nachman, S., Maama, L.B., and El-Sadr, W.M., 2021. Improving child tuberculosis contact identification and screening in Lesotho: Results from a mixed-methods cluster-randomized implementation science study. PloS One. 2021 May 20;16(5):e0248516. PMID: 34014956.
  2. Ismail, N.A., Omar, S.V., Moultrie, H., Bhyat, Z., Conradie, F., Enwerem, M., Ferreira, H., Hughes, J., Joseph, L., Kock, Y., Letsaolo, V., Maartens,, Meintjes, G., Ngcamu, D., Okozi, N., Padanilam, X., Reuter, A., Romero, R., Schaaf, S., Te Riele, J., Variava, E., van der Meulen, M., Ismail, F., and Ndjeka, N. Assessment of epidemiological and genetic characteristics and clinical outcomes of resistance to bedaquiline in patients treated for rifampicin-resistant tuberculosis: A cross-sectional and longitudinal study. The Lancet Infectious Diseases. 2021 Nov 12. PMID: 34780706.
  3. Johara, F.T., Benedetti, A., Platt, R., Menzies, D., Viiklepp, P., Schaaf, S., and Chan, E. Evaluating the performance of propensity score matching based approaches in individual patient data meta-analysis. BMC Medical Research Methodology. 2021 Dec;21(1):1-6. PMID: 34814845.
  4. Lange, C., Aaby, P., Behr, M.A., Donald, P.R., Kaufmann, S.H., Netea, M.G., and Mandalakas, A.M. 100 years of Mycobacterium bovis bacille Calmette-Guérin. The Lancet Infectious Diseases. 2021 Sep 7. PMID: 34506734.
  5. Lawrence, D.S., Tsholo, K., Ssali, A., Mupambireyi, Z., Hoddinott, G., Nyirenda, D., et al. The lived experience of participants in an African randomised trial (LEOPARD): Protocol for in-depth qualitative study within a multisite randomised controlled trial for HIV-associated cryptococcal meningitis. BMJ Open. 2021 Apr 1;11(4):e039191. PMID: 33820784.
  6. LOVEDAY M, HUGHES JA, SUNKARI B, MASTER I, HLANGU S, REDDY T, CHOTOO S, GREEN N, SEDDON JA. Maternal and infant outcomes among pregnant women treated for multidrug/rifampicin-resistant tuberculosis in South Africa. Clinical Infectious Diseases2021; 72(7):1158-1168.

 

  1. Marais, B.J., Verkuijl, S., Casenghi, M., Triasih, R., Hesseling, A.C., Mandalakas, A.M., Marcy, O., Seddon, J.A., Graham, S.M., and Amanullah, F. Paediatric tuberculosis–new advances to close persistent gaps. International Journal of Infectious Diseases. 2021 Mar 11. PMID: 33716193.
  2. Mandalakas, A.M., Hesseling, A.C., Kay, A., Du Preez, K., Martinez, L., Ronge, L., DiNardo, A., Lange, C., and Kirchner, H.L. Tuberculosis prevention in children: A prospective community-based study in South Africa. Eur Respir J. 2021 Apr 22;57(4):2003028. PMID: 33122339.
  3. Manyelo, C.M., Chegou, N.N., Seddon, J.A., Snyders, C.I., Mutavhatsindi, H., Manngo, P.M., Walzl, G., Stanley, K., and Solomons, R.S., 2021. Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis. Plos One. 2021 Apr 30;16(4):e0250944. PMID: 33930055.
  4. MARX FM, HAUER B, MENZIES NA, HAAS W, PERUMAL N. Targeting screening and treatment for latent tuberculosis infection towards asylum seekers from high-incidence countries – a model-based cost-effectiveness analysis. BMC Public Health 2021; 21:2172.
  5. Meyerson, K., Hoddinott, G., Nicholson, T., and Meehan, S.A. 2021. Underlying reasons why some people haven’t tested for HIV–a discourse analysis of qualitative data from Cape Town, South Africa. SAHARA-J: Journal of Social Aspects of HIV/AIDS. 2021 Nov 2;18(1):105-12. PMID: 34514958.
  6. Migliori, G.B., Marx, F.M., Hoddinot, G., Ambrosino, N., Zampogna, E., Schaaf, H.S., van der Zalm. M.M., … and Visca D. Clinical standards for the assessment, management, and rehabilitation of post-TB lung disease. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):797-813. PMID: 34615577.
  7. Migliori, G.B., Visca, D., van den Boom, M., Tiberi, S., Rossato Silva, D., Centis, R., D’Ambrosio, L., Thomas, T., Pontali, E., Saderi, L., Schaaf, H.S., Sotgiu, G., and contributing members of the Global Tuberculosis Network. Tuberculosis, COVID-19 and hospital admission: Consensus on pros and cons based on a review of the evidence. Pulmonology. 2021 Jan 28(3):248-256.
  8. Moscibrodzki, P., Enane, L.A., Hoddinott, G., Brooks, M.B., Byron, V., Furin, J., Seddon, J.A., Meyersohn, L., and Chiang, S.S. The impact of tuberculosis on the well-being of adolescents and young adults. Pathogens. 2021 Dec;10(12):1591. PMID: 34959546.
  9. Mubekapi-Musadaidzwa, C., Wademan, D., Peton, N., Hendricks, P., Carolus, G., Mbaezue, R., Kelley, K.F., Kruger, J., Jennings, K., Grobbelaar, N., and Louis, F. Motivating people living with HIV to initiate antiretroviral treatment outside national guidelines in three clinics in the HPTN 071 (PopART) trial, South Africa. African Journal of AIDS Research. 2021 Jan 2;20(1):32-41. PMID: 33635735.
  10. Myburgh, H., Reynolds, L., Hoddinott, G., van Aswegen, D., Grobbelaar, N., Gunst, C., Jennings, K., Kruger, J., Louis, F., Mubekapi-Musadaidzwa, C., and Viljoen, L. Implementing ‘universal’ access to antiretroviral treatment in South Africa: A scoping review on research priorities. Health Policy and Planning. 2021 May 8. PMID: 33963393.
  11. NACHEGA JB, VAN DER ZALM MM, KRUGER M, WIYSONGE CSU, PALEKER M, MAHOMED H, ET AL. Addressing challenges to rolling out COVID-19 vaccines in African countries. Lancet Global Health 2021; 9(6):e746-e748.
  12. Nel Van Zyl, K., Whitelaw, A.C., Hesseling, A.C., Seddon, J.A., Demers, A.M., and Newton-Foot, M. Association between clinical and environmental factors and the gut microbiota profiles in young South African children. Scientific Reports. 2021 Aug 5;11(1):15895. PMID: 34354176.
  13. Noguera-Julian, A., Buonsenso, D., Mckenna, L., Seddon, J.A. and Ritz, N. Availability of fixed-dose, child-friendly formulations of first-line tuberculosis drugs in Europe. European Respiratory Journal. Online ahead of print. 2021 Jan 1. PMID: 34049946.
  14. NORTHRUP GR, QIAN L, BRUXVOORT K, MARX FM, WHITTLES LK, LEWNARD A. Inference of naturally acquired immunity using a self-matched negative-control design. EPIDEMIOLOGY 2021; 32:168-178.
  15. Olbrich, L., Stockdale, L., Basu Roy, R., Song, R., Whittaker, E., Prendergast, A., Cicini-Sain, L., Fletcher, H., and Seddon, J.A. Understanding the interaction between cytomegalovirus and tuberculosis in children: The way forward. Plos Path. 2021 Dec 9;17(12):e1010061. PMID: 34882748.
  16. Osman, M., Karat, A.S., Khan, M., Meehan, S., von Delft, A., Brey, Z., Charalambous, S., Hesseling, A.C., Naidoo, P., and Loveday, M. Health system determinants of tuberculosis mortality in South Africa: A causal loop model. BMC Health Serv Res. 2021 Dec;21(1):1-1. PMID: 33902565.
  17. Osman, M., Meehan, S.A., von Delft, A., Du Preez, K., Dunbar, R., Marx, F.M., Boulle, A., Welte, A., Naidoo, P., and Hesseling, A.C. Early mortality in tuberculosis patients initially lost to follow up following diagnosis in provincial hospitals and primary health care facilities in Western Cape, South Africa. Plos One. 2021 Jun 14;16(6):e0252084. PMID: 34125843.
  18. Osman, M., du Preez, K., Seddon, J.A., Claassens, M.M., Dunbar, R., Dlamini, S.S., Welte, A., Naidoo, P., and Hesseling, A.C. Mortality in South African children and adolescents routinely treated for tuberculosis. Pediatrics. 2021 Apr 1;147(4). PMID: 33692161
  19. Osman, M., van Schalkwyk, C., Naidoo, P., Seddon, J.A., Dunbar, R., Dlamini, S.S., Welte, A., Hesseling, A.C., and Claassens, M.M. Mortality during tuberculosis treatment in South Africa using an 8-year analysis of the national tuberculosis treatment register. Scientific Reports. 2021 Aug 5;11(1):1-0. PMID: 34354135.
  20. Osman, M., Verster, J., Dempers, J.J., Du Preez, K., von Delft, A., Dunbar, R., Welte, A., Naidoo, P., and Hesseling, A.C. Tuberculosis in persons with sudden unexpected death, in Cape Town, South Africa. International Journal of Infectious Diseases. 2021 Apr 1;105:75-82. PMID: 33582368.
  21. Pickles, M., Cori, A., Probert, W.J., Sauter, R., Hinch, R., Fidler, S., Ayles, H., Bock, P., Donnell, D., Wilson, E., and Piwowar-Manning, E. PopART-IBM, a highly efficient stochastic individual-based simulation model of generalised HIV epidemics developed in the context of the HPTN 071 (PopART) trial. PLoS Computational Biology. 2021 Sep 2;17(9):e1009301. PMID: 34473700.
  22. PILLAY-FUENTES LORENTE V, BEKKER A, KALI GTJ, LLOYD LG, ABULFATHI AA, DECLOEDT EH. The Pharmacokinetics of crushed levetiracetam tablets administered to neonates. JOURNAL OF TROPICAL PEDIATRICS 2021; 67(2):fmab041.
  23. Purchase, S., Batist, E., Mmile, N., Nkosi, S., Workman, J., Martinson, N., Fairlie, L., Schaaf, H.S., Choo, L., McGowan, C., Crook, A.M., Seddon, J.A., and Hesseling, A.C. Challenges in recruiting children to a multidrug-resistant TB prevention trial. Int J Tuberc Lung Dis. 2021 Oct 1;25(10):814-22. PMID: 34615578.
  24. Radtke, K.K., Hibma, J.E., Hesseling, A.C., and Savic, R.M. Pragmatic global dosing recommendations for the 3-month, once-weekly rifapentine and isoniazid preventive TB regimen in children. Eur Respir J. 2021 Jan 5;57(1):2001756. PMID: 32703775.
  25. Radtke, K.K., Hesseling, A.C., Winckler, J.L., Draper, H.R., Solans, B.P., Thee, S., Wiesner, L., van der Laan, L.E., Fourie, B., Nielsen, J., and Schaaf, H.S. Moxifloxacin pharmacokinetics, cardiac safety, and dosing for the treatment of rifampicin-resistant tuberculosis in children. Clinical Infectious Diseases [Online ahead of print]. 2021 Jul 21. PMID: 34286843.
  26. Ronge, L., Sloot, R., Du Preez, K., Kay, A.W., Kirchner, H.L., Grewal, H.M., Mandalakas, A.M., and Hesseling, A.C. The magnitude of interferon gamma release assay responses in children with household tuberculosis contact is associated with tuberculosis exposure and disease status. The Pediatric Infectious Disease Journal. 2021 Jul 12;40(8):763-70. PMID: 34050092.
  27. ROY RB, BAKEERA-KITAKA S, CHABALA C, GIBB D, HUYNH J, MUJURU H, SANKHYAN N, SEDDON JA, SHARMA S, SINGH V, WOBUDEYA E, ANDERSON ST. Defeating paediatric tuberculous meningitis: Applying the WHO “Defeating Meningitis by 2030: Global Roadmap”. Microorganisms 2021; 9:857.
  28. Schaaf, H.S., and Seddon, J.A. Management of tuberculous meningitis in children. Paediatr Int Child Health. 2021 Nov 16:1-6. PMID: 34783305.
  29. SEDDON JA, JOHNSON S, PALMER M, VAN DER ZALM MM, LOPEZ VARELA EB, HUGHES JA, SCHAAF HS. Multidrug-resistant tuberculosis in children and adolescents: current strategies for prevention and treatment. Expert Review of Respiratory Medicine 2021; 15(2):221-237.
  30. Solomons, R.S., Nieuwoudt, S.T., Seddon, J.A., and van Toorn, R. Risk factors for ischaemic stroke in children with tuberculous meningitis. J Child Neurol 2021. PMID: 33856542.
  31. Spies, G., Ahmed-Leitao, F., Hoddinott, G., and Seedat, S. Effects of unhealthy alcohol use on brain morphometry and neurocognitive function among people with HIV. Journal of NeuroVirology. 2021 Dec 9:1-1. PMID: 34882280.
  32. Thomas, R., Probert, W.J., Sauter, R., Mwenge, L., Singh, S., Kanema, S., Vanqa, N., Harper, A., Burger, R., Cori, A., and Pickles, M. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: Evidence and projections from the HPTN 071 (PopART) trial. The Lancet Global Health. 2021 May 1;9(5):e668-80. PMID: 33721566.
  33. Van der Laan, L.E., Garcia-Prats, A.J., Schaaf, H.S., Winckler, J.L., Draper, H., Norman, J., Wiesner, L., McIlleron, H., Denti, P., and Hesseling, A.C. Pharmacokinetics and drug-drug interactions of Abacavir and Lamuvudine co-administered with antituberculosis drugs in HIV-positive children treated for multidrug-resistant tuberculosis. 2021 Oct 8;12:722204. eCollection. PMID: 34690765.
  34. VAN DER ZALM MM, LISHMAN J, VERHAGEN LM, REDFERN A, BARDAY MM, RUTTENS DLP, DA COSTA A, ITANA JN, SCHRUEDER N, VAN SCHALKWYK M, PARKER NM, APPEL IN, FOURIE B, CLAASSEN M, WORKMAN JJ, GOUSSARD P, VAN ZYL GU, RABIE H. Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2–Related Illness in Children: Hospital Experience in Cape Town, South Africa. Clinical Infectious Diseases 2021; 72(12):e938-44.
  35. VAN DER ZALM MM, LISHMAN J, VERHAGEN LM, REDFERN A, SMIT EJ, BARDAY M, RUTTENS DLP, DA COSTA A, SEBITOSI-VAN JAARSVELD SNN, ITANA JN, SCHRUEDER N, VAN SCHALKWYK M, PARKER NM, APPEL IN, FOURIE B, CLAASSEN M, WORKMAN JJ, GOUSSARD P, VAN ZYL GU, RABIE H. Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa. Clinical Infectious Diseases 2021; 72(12):e3938-e944.
  36. Van Heerden, J.K., van Zyl, A., Schaaf, H.S., Goussard, P., Frigati, L.J., and Rabie, H. Childhood cancers misdiagnosed as tuberculosis in a high tuberculosis burden setting. Pediatr Infect Dis J. 2021 Nov 8;40(12):1076-80. Online ahead of print. PMID: 34508025
  37. VAN TOORN R, SOLOMONS RS, SEDDON JA, SCHOEMAN JF. Thalidomide use for complicated central nervous system tuberculosis in children: insights from an observational cohort. Clinical Infectious Diseases 2021; 72(5):e136-45.
  38. Van Toorn, R., Zaharie, S.D., Seddon, J.A., van der Kuip, M., van Furth, A.M., Schoeman, J.F., and Solomons, R.S. The use of thalidomide to treat children with tuberculosis meningitis: A review. Tuberculosis. 2021 Sep 1;130:102125. PMID: 34500217.
  39. Van der Westhuizen, A., Dramowski, A., Schaaf, H.S., Groenewald, M., and Bekker, A. Hospital-based evaluation of a tuberculosis-exposed neonate: An approach to complement the national guidance. S Afr J Med 2021;111(8):724-728.
  40. Vanqa, N., Hoddinott, G., Mbenyana, B., Osman, M., and Meehan, S.A. Linkage to TB care – a qualitative study to understand linkage from the patients’ perspective in the Western Cape Province, South Africa. PLOS ONE. 2021 Nov 19;16(11):e0260200. PMID: 34797855.
  41. VILJOEN L, BOND V, REYNOLDS LJ, MUBEKAPI-MUSADAIDZWA C, BALOYI DP, NDUBANI R, STANGL A, SEELEY J, PLIAKAS T, BOCK PA, FIDLER S, HAYES R, AYLES H, HARGREAVES JR, HODDINOTT G. Universal HIV testing and treatment and HIV stigma reduction: a comparative thematic analysis of qualitative data from the HPTN 071 (PopART) trial in South Africa and Zambia. SOCIOLOGY OF HEALTH & ILLNESS 2021; 43(1):167-185.
  42. Viljoen, L., Hoddinott, G., Malunga, S., Vanqa, N., Mhlakwaphalwa, T., Marthinus, A., Mcimeli, K., Bond, V., Seeley, J., Bock, P., and Hayes, R. Women’s sexual scripting in the context of universal access to antiretroviral treatment—findings from the HPTN 071 (PopART) trial in South Africa. BMC Women’s Health. 2021 Dec;21(1):1-3. PMID: 34689783.
  43. Viljoen, L., Mainga, T., Casper, R., Mubekapi-Muzadaidzwa, C., Wademan, D.T., Bond, V.A., Pliakas, T., Bwalya, C., Stangl, A., Phiri, M. Yang, B., and Hoddinott, G. on behalf of the HPTN 071 (PopART) team. Community-based health workers implementing universal access to HIV testing and treatment: Lessons from South Africa and Zambia-HPTN 071 (PopART). Health Policy and Planning. PMID: 33963387.
  44. VILJOEN L, MYBURGH H, REYNOLDS LJ. “It stays between us”: Managing comorbidities and public/private dichotomies in HPTN071 (POPART) trial communities. Medical Anthropology 2021; 40(3):280-293.
  45. Viljoen, L., Wademan, D., Hoddinott, G., Bond, V., Seeley, J., Bock, P., Fidler, S., Reynolds, L., and HPTN 071 (PopART) team. The act of telling: South African women’s narratives of HIV status disclosure to intimate partners in the HPTN 071 (PopART) HIV prevention trial. Women’s Health. 2021 Jan-Dec;17:1745506521998204. PMID: 33645374.
  46. Wademan, D.T., Mainga, T., Gondwe, M., Ayles, H., Shanaube, K., Mureithi, L., Bond, V., and Hoddinott, G. on behalf of the TREATS study team. ‘TB is a disease which hides in the body’: Qualitative data on conceptualisations of tuberculosis recurrence among patients in Zambia and South Africa. Global Public Health. 2021 Jun 30:1-15. PMID: 34187320.
  47. Winckler, J.L., Schaaf, H.S., Draper, H.R., McIlleron, H., Norman, J., van der Laan, L.E., Wiesner, L., Donald, P.R., Hesseling, A.C., and Garcia-Prats, A.J. Pharmacokinetics of high-dose isoniazid in children affected by multidrug-resistant TB. Int J Tuberc Lung Dis. 2021 Nov 1;25(11):896-902. PMID: 34686231
  48. World Health Organization. Rapid communication on updated guidance on the management of tuberculosis in children and adolescents [Internet]. Geneva: World Health Organization. 2021. Available from: https://www.who.int/publications/i/item/9789240033450

 

 

 

 

Posted on 4 February 2022 under Publications

Recent Posts

All content © 2024 Desmond Tutu TB Centre, Stellenbosch University. All Rights Reserved.

The University of Stellenbosch

Share this page:

Website by AO Design